ES8706312A1 - Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas. - Google Patents

Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Info

Publication number
ES8706312A1
ES8706312A1 ES546583A ES546583A ES8706312A1 ES 8706312 A1 ES8706312 A1 ES 8706312A1 ES 546583 A ES546583 A ES 546583A ES 546583 A ES546583 A ES 546583A ES 8706312 A1 ES8706312 A1 ES 8706312A1
Authority
ES
Spain
Prior art keywords
preparation
slurry
lyophilized compositions
syringe
aminocaproic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546583A
Other languages
English (en)
Other versions
ES546583A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Pharmaceutical Partners
Original Assignee
Serono Pharmaceutical Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Pharmaceutical Partners filed Critical Serono Pharmaceutical Partners
Publication of ES546583A0 publication Critical patent/ES546583A0/es
Publication of ES8706312A1 publication Critical patent/ES8706312A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

METODO PARA LA PREPARACION DE UN COMPUESTO PARA CURAR CICATRICES CUTANEAS HUNDIDAS. COMPRENDE LAS OPERACIONES CONSISTENTES EN OBTENER PLASMA Y EN PREPARAR SEGUIDAMENTE UNA MEZCLA LIOFILIZADA DE GELATINA EN POLVO ABSORBIBLE Y ACIDO AMINOCAPROICO, EN LA CUAL HAYA APROXIMADAMENTE ENTRE 20 Y 50 PARTES DE GELATINA EN POLVO POR CADA 12 A 75 PARTES DE ACIDO AMINOCAPROICO; EN INTRODUCIR EL PLASMA EN UNA JERINGA Y LA MEZCLA LIOFILIZADA EN UNA SEGUNDA JERINGA EN UNA CANTIDAD TAL QUE LA GELATINA EN POLVO ABSORBIBLE ESTE ENTRE 40 Y 100 MILIGRAMOS Y LA CANTIDAD DE ACIDO AMINOCAPROICO ESTE COMPRENDIDA ENTRE 25 Y 150 MILIGRAMOS, POR CADA 2 CM DE PLASMA CONTENIDOS EN LA JERINGA QUE CONTIENE EL PLASMA; Y EN INTERCONECTAR EL CONTENIDO DE AMBAS JERINGAS HASTA OBTENER UNA MEZCLA ADECUADA. DE APLICACION EN EL TRATAMIENTO DE CICATRICES PROVOCADAS POR ACNE VULGARIS, VARICELA, HERPES Y CIRUGIA.
ES546583A 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas. Expired ES8706312A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/442,151 US4540410A (en) 1982-11-16 1982-11-16 Lyophilized compositions, preparation and use thereof

Publications (2)

Publication Number Publication Date
ES546583A0 ES546583A0 (es) 1987-07-01
ES8706312A1 true ES8706312A1 (es) 1987-07-01

Family

ID=23755732

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527289A Expired ES8600733A1 (es) 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico
ES546583A Expired ES8706312A1 (es) 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES527289A Expired ES8600733A1 (es) 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico

Country Status (12)

Country Link
US (1) US4540410A (es)
EP (1) EP0109188B1 (es)
AT (1) ATE24838T1 (es)
AU (1) AU558164B2 (es)
CA (1) CA1228542A (es)
DE (1) DE3369070D1 (es)
DK (1) DK164538C (es)
ES (2) ES8600733A1 (es)
IL (1) IL69923A (es)
NO (1) NO165625C (es)
PT (1) PT77621B (es)
ZA (1) ZA837407B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4743229A (en) * 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
DE3816961A1 (de) * 1987-07-21 1989-02-02 Wasserburger Arzneimittelwerk Injektionsspritze fuer medizinische zwecke
EP0365704A1 (de) * 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopräparat für Hämostase bei Magenblutungen
US5063178A (en) * 1990-03-19 1991-11-05 Medex, Inc. Freeze-dried blood gas sensor
FR2694496A1 (fr) * 1992-08-05 1994-02-11 Bernstein Serge Procédé pour l'obtention d'un produit permettant l'expansion des seins et le traitement des rides.
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) * 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6527738B1 (en) * 1999-04-30 2003-03-04 Prismedical Corporation Drug delivery pack
US20010037091A1 (en) * 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7998106B2 (en) 2004-05-03 2011-08-16 Thorne Jr Gale H Safety dispensing system for hazardous substances
US7101354B2 (en) 2004-05-03 2006-09-05 Infusive Technologies, Llc Mixing syringe with and without flush
AU2007267338B2 (en) * 2006-05-31 2013-04-04 Baxter Healthcare S.A. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
JP5569398B2 (ja) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー／エス 止血および／または創傷治癒を促進するための装置
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
AU2010262058B2 (en) * 2009-06-16 2013-08-29 Baxter Healthcare S.A. Hemostatic sponge
JP2013514093A (ja) 2009-12-16 2013-04-25 バクスター・インターナショナル・インコーポレイテッド 止血スポンジ
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
WO2011151386A1 (en) * 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
MX344402B (es) 2010-06-01 2016-12-14 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
MX356185B (es) 2011-10-11 2018-05-17 Baxter Int Composiciones hemostaticas.
EP2766058B1 (en) 2011-10-11 2022-11-23 Baxter International Inc. Hemostatic compositions
CN103889447B (zh) 2011-10-27 2015-11-25 巴克斯特国际公司 止血组合物
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
CA2874290C (en) 2012-06-12 2020-02-25 Ferrosan Medical Devices A/S Dry haemostatic composition
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
CN112368028A (zh) 2018-05-09 2021-02-12 弗罗桑医疗设备公司 用于制备止血组合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB450145A (en) * 1934-01-13 1936-07-06 Sharp & Dohme Inc Lyophilic biologically active substances and process of producing the same
GB455027A (en) * 1935-01-04 1935-08-01 Sharp & Dohme Inc Normal serum product and process of producing the same
US2380339A (en) * 1941-07-10 1945-07-10 Fromm Lab Inc Method and apparatus for preserving biological substances
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4191751A (en) * 1975-06-04 1980-03-04 Gottlieb Sheldon K Method for promoting growth of new connective tissue over surface wounds
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue

Also Published As

Publication number Publication date
NO165625C (no) 1991-03-13
ES546583A0 (es) 1987-07-01
ATE24838T1 (de) 1987-01-15
AU2091683A (en) 1984-05-24
ZA837407B (en) 1985-05-29
NO834183L (no) 1984-05-18
ES527289A0 (es) 1985-11-01
IL69923A (en) 1987-03-31
PT77621B (en) 1986-03-19
AU558164B2 (en) 1987-01-22
DK164538B (da) 1992-07-13
DK521283A (da) 1984-05-17
ES8600733A1 (es) 1985-11-01
EP0109188B1 (en) 1987-01-14
CA1228542A (en) 1987-10-27
DK521283D0 (da) 1983-11-15
EP0109188A1 (en) 1984-05-23
DK164538C (da) 1993-01-11
DE3369070D1 (en) 1987-02-19
US4540410A (en) 1985-09-10
NO165625B (no) 1990-12-03
PT77621A (en) 1983-12-01

Similar Documents

Publication Publication Date Title
DE3369070D1 (en) Lyophilized compositions, preparation and use thereof
DE3071262D1 (en) Use of a copolymer of acrylic acid and maleic acid as mixing component for glass-ionomer cements
ZA899372B (en) Hemostatic collagen paste composition
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS5523110A (en) Grout and grouting method
JPS557016A (en) Extraction of aqueous growth accelerating liquid
JPS5650958A (en) Resin composition
GB1364113A (en) Plaster compositions and methods of setting plaster compositions
JPS55124461A (en) Preparation of fish breeding feed
JPS5224879A (en) Mixed feed for land produced shellfish
JPS52100553A (en) Preparation of resin compositions
JPS57171405A (en) Solid defoaming agent and preparation thereof
GB1270760A (en) Improvements relating to quick setting portland cement compositions
JPS642518A (en) Culture net for laver
JPS5389288A (en) Fluorescent lamp
JPS5626808A (en) Dental cement composition
JPS5620505A (en) Dental eugenol cement
AU553460B2 (en) Hydrolitic agglomeration of coal and its application to the preparation of coal slurry fuel mixture
JPS52109503A (en) Preparation of formed coke
JPS5781892A (en) Method for non-polluting and solidifying harmful material sludge
JPS56129290A (en) Modification of ground
JPS5793914A (en) Stabilizing method of scopolia root extract in pharmaceutical
JPS5421496A (en) Preparation of polyester having high polymerization degree
JPS5234911A (en) Preparation of exudations
AU460540B2 (en) Mixing and delivery of cement grout

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505